why is my glp 1 injection site itchy Rash from a GLP-1 explained by an allergist 👆, Thanks to friend @rubin_allergy for the information in this video The most recommended injection sites

If side effects are severe, taking a lower dose temporarily can help the body adjust

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

In 2023 Lilly published results of its phase 2 trial for orforglipron, a once-daily oral drug which achieved up to 14.7% mean weight reduction at 36 weeks, and Pfizer has completed phase 2 trial for its oral drug danuglipron and is now optimising the formulation

1 Of the 145,410 patients treated with GLP1 and 291,667 treated with dipeptidyl peptidase 4 (DPP4) inhibitor treatment, 76 and 184, respectively, developed thyroid cancer

OKane M, Pinkney J, Aasheim ET, Barth JH, Batterham RL